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Edited by Amy McGoughAbstract Coactosin is a small (MW 15 kDa) evolutionarily
conserved actin ﬁlament binding protein. It displays remote
sequence homology to ADF/coﬁlin proteins and to the ADF-H
domains of twinﬁlin and Abp1/drebrin. However, biochemical
analyses have demonstrated that coactosin has a very diﬀerent
role in actin dynamics from the ones of ADF/coﬁlin, twinﬁlin or
Abp1/drebrin. To elucidate the molecular mechanism of coact-
osin/actin interaction, we determined the three-dimensional
structure of mouse coactosin by multidimensional NMR spec-
troscopy. We ﬁnd that the coactosin structure is homologous to
ADF/coﬁlin and to the ADF-H domains of twinﬁlin. Further-
more, the regions that have been shown to be important for actin
ﬁlament interactions in ADF/coﬁlins are structurally conserved
in coactosin suggesting that these two proteins interact with F-
actin through a conserved interface. Our analysis also identiﬁes
key structural diﬀerences between these proteins that may
account for the diﬀerences in biochemical activities and cellular
roles of these proteins.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Dynamic changes in the actin cytoskeleton of eukaryotic
cells are regulated by a large number of actin-binding pro-
teins. Many of these proteins have evolved as a result of
gene duplications and thus they are composed of a small
number of actin-binding motifs. One of the most charac-
terized actin-binding motif is the ADF homology (ADF-H)
domain, which is present in at least three distinct groups of
actin binding proteins: ADF/coﬁlins, twinﬁlins, and Abp1/
drebrins [1]. Each group of ADF-H proteins shows unique
actin-binding properties and biological activities. ADF/coﬁ-
lins are small (15–20 kDa) essential proteins that are entirely* Corresponding author. Fax: +358-9-191-59541.
E-mail address: perttu.permi@helsinki.ﬁ (P. Permi).
Abbreviations: ADF, actin depolymerizing factor; HSQC, heteronu-
clear single quantum coherence; NOE, nuclear Overhauser enhance-
ment; NOESY, NOE spectroscopy; TROSY, transverse relaxation
optimized spectroscopy
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doi:10.1016/j.febslet.2004.08.068composed of one ADF-H domain. They bind both ﬁla-
mentous and monomeric actin and promote rapid actin
dynamics by severing ﬁlaments and catalyzing the dissocia-
tion of actin monomers from the ﬁlament pointed ends [2].
Twinﬁlins consist of two ADF-H domains separated by a
short linker region. In contrast to ADF/coﬁlins, twinﬁlins
bind only monomeric actin. The exact biological role of
twinﬁlins is unknown, but they have been proposed to
contribute to cytoskeletal dynamics by sequestering actin
monomers and by localizing them to the sites of rapid actin
assembly in cells [3,4]. Abp1/drebrins are relatively large
proteins consisting of an N-terminal ADF-H domain, a
variable region, and a C-terminal SH3 domain. These pro-
teins bind only ﬁlamentous actin. Biochemical and genetic
studies on yeast Abp1 have shown that this protein links
Srv2/CAP family of actin monomer binding proteins to actin
ﬁlaments and promotes actin ﬁlament nucleation through
the activation of Arp2/3 complex [5–7].
In addition to the three classes of ADF-H domain proteins
described above, also a fourth class of proteins, coactosins,
may contain an ADF-H domain. However, due to low se-
quence homology to other ADF-H domain proteins and due
to the lack of certain key sequence features, it has been un-
clear if coactosin is indeed an ADF-H domain protein.
Coactosin was originally identiﬁed as a 17 kDa protein
copurifying with Dictyostelium discoideum actomyosin com-
plexes [8]. More recently, coactosin homologs have been
identiﬁed from Drosophila, Xenopus and mammals [9]. Simi-
larly to ADF/coﬁlins, coactosin is composed of only one
putative ADF-H domain. The amino acid sequences of co-
actosins from diﬀerent species are 15–25% identical to other
ADF-H family members, showing the highest level of ho-
mology with the N-terminal ADF-H domain of Abp1. Bio-
chemical studies demonstrated that coactosins bind actin
ﬁlaments with relatively weak aﬃnity and do not interact
with actin monomers [8,9]. Dictyostelium discoideum coacto-
sin was also reported to show a weak uncapping activity [10].
In addition, Provost et al. [11] demonstrated that mouse
coactosin binds 5-lipoxygenase, an enzyme involved in leu-
kotriene biosynthesis, although the biological role of this
interaction is unknown. First cell biological studies suggest
that coactosin colocalizes with the actin cytoskeleton in cul-
tured cells [8,9]. However, the cell biological role and the
mechanism by which coactosin contributes to cytoskeletal
dynamics are currently unclear.blished by Elsevier B.V. All rights reserved.
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ADF-H domain proteins, we determined the solution struc-
ture of mouse coactosin by NMR spectroscopy. Our results
conﬁrm that the overall three-dimensional fold of coactosin is
the typical ADF-H domain fold. The actin ﬁlament binding
regions of ADF/coﬁlins are also well conserved in the
structure of coactosin. However, we also identiﬁed structural
diﬀerences between coactosin and other ADF-H domain
proteins and propose that these may account for the diﬀer-
ences in the actin-binding characteristics between these actin
regulatory proteins.2. Materials and methods
2.1. Expression and puriﬁcation of the mouse coactosin
Recombinant mouse coactosin (GenBank Accession No. AI325867)
was expressed in E. coli BL21(DE3) cells, transformed with a pRAT5
plasmid containing the coactosin gene. Cells were grown in M9
media containing either 15NH4Cl (1 g/l) or
15NH4Cl (1 g/l) and
13C-glucose (2 g/l) as the sole sources of nitrogen and carbon,
respectively.
The high-speed supernatant was ﬁrst loaded onto a Q-Sepharose
Fast Flow anion exchange column (Pharmacia) in 20 mM Tris–HCl,
pH 8.0, and eluted with a linear NaCl gradient from 0 to 1 M NaCl.
The fractions containing the coactosin protein were then applied to a
CHT II Hydroxyl-apatite column (Bio-Rad) and eluted with a linear
KPO4 gradient from 0 to 250 mMKPO4, pH 7.0. After this, the purest
fractions were concentrated to less than 2 ml and applied to a Superdex
75 16/60 gel ﬁltration column in 50 mM NaCl, 0.1% NaN3, 10 mM
Bis–Tris, pH 6.0, from where it eluted as a single peak at around 70 ml
volume, indicative of a monomeric protein. All samples were subse-
quently concentrated to 1–1.2 mM solution and veriﬁed (mass-spec-
trometry) to be >99% 15N- or 15N, 13C-labeled. The yield of puriﬁed
protein was 55 mg/liter, which was comparable to the yield obtained
from expression in rich medium.
For the NMR studies, samples of 1–1.2 mM coactosin in 10 mM
Bis–Tris (pH 6.0), 50 mM NaCl, 1 mM DTT and H2O/D2O (9:1) were
prepared. For the amide proton exchange studies protein was lyophi-
lized and dissolved in D2O. Residual dipolar couplings (RDC) were
measured in ﬁlamentous phage (Pf1) liquid-crystalline medium at a
concentration 4.5 mg/ml with 10 mM Bis–Tris buﬀer, pH 6.5, and 50
mM NaCl.
2.2. NMR spectroscopy
All spectra were acquired at 25 C using Varian INOVA 600 and 800
MHz spectrometers. The sequence-speciﬁc resonance assignments of
1H/13C/15N nuclei were obtained with completeness over 98% [12]. In
addition, methyl proton assignments were conﬁrmed by using 3D DE-
MQ-(H)CCMHM-TOCSY spectrum [13]. A complete assignment of
aromatic side-chains was facilitated by the identiﬁcation of aromatic d
protons from (HB)CB(CGCD)HD [14]. The remaining aromatic pro-
tons were assigned using 2D 1H–1H-nuclear Overhauser enhancement
spectroscopy (NOESY), recorded with 80 and 100 ms mixing times
from the sample dissolved in 100% D2O and 3D NOESY-
13C-heter-
onuclear single quantum coherence (HSQC) spectra.
The distance information was collected using 3D NOESY-15N-
HSQC [15] and NOESY-13C-HSQC [16], modiﬁed to excite aliphatic
and aromatic 13C resonances simultaneously, with 100 ms mixing
times. 1DHN and
1DCaC0 RDCs were obtained using the spin-state-
selective transverse relaxation optimized spectroscopy (TROSY) [17]
and HNCO(a=b-C0Ca-J) [18] experiments. 1DNC0 and
2DHNC0 dipolar
couplings were measured using the HN(a=b-NC0-J)-TROSY experi-
ment [19].
The data sets were processed using the Vnmr software package
(Varian Inc., Palo Alto, CA, USA) and analyzed by Sparky version
3.106 [20]. The 15N longitudinal (T1) and transverse (T2) relaxation
data were collected as described earlier [21]. Nine time points per se-
ries, delays ranging from 0.01 to 2.1 s for T1 and from 10 to 250 ms for
T2, were used for non-linear sampling of relaxation. The relaxation
times were calculated by ﬁtting cross peak intensities to a single ex-
ponentially decaying function using the Sparky software.2.3. Structure determination and analysis
NOE cross peaks, obtained from two 3D NOESY spectra, were
assigned using the NOEASSIGN algorithm of CYANA 2.0.26 [22].
The standard protocol of seven cycles of iterative NOE assignments
and structure calculations resulted in a total of 2435 NOE upper
distance limits. 135 torsion angle restraints were generated with the
program TALOS [23]. From the family of 100 calculated structures,
15 with lowest target function were selected for further reﬁnement
and analysis.
In total, 64 1DHN and 56
1DCACO RDCs were included in structure
reﬁnement using the simulated annealing and energy minimization
protocols in the program XPLOR-NIH [24]. Substantial line broad-
ening in the Pf1 liquid crystal medium allowed us to collect only
limited set of RDCs with a suﬃcient precision. All the RDCs were
normalized to 1DHN. The axial component of alignment tensor Ak
and rhombicity R were obtained using the extended histogram
method (EHM) [25] to give Ak ¼ 10:26 and R ¼ 0:59 that were used
in the reﬁnement. Additional 27 hydrogen bond restraints were de-
ﬁned on the basis of slowly exchanging amide protons and regular
secondary structure elements analyzed from structures calculated with
CYANA.3. Results
3.1. Structure determination of coactosin
In the structure determination based on NOEs, the CYANA
program was able to deﬁne 2435 distance limits from the total
number of 5249 observed NOE cross peaks. The root mean
square deviation (RMSD) for the backbone atoms N, CA, CO
(residues 3–130) was 0.76 A and for the backbone heavy atoms
1.14 A. When the disordered loop region between the b-sheets
4 and 5 (residues 65–73) was excluded, the corresponding
RMSD values were 0.39 and 0.84 A, respectively. Structural
statistics is summarized in Table 1. The structure with the
lowest CYANA target function value was reﬁned against
RDCs. Also hydrogen bond restraints were used in the re-
ﬁnement. Owing to the small number of RDCs the precision
did not improve (see Table 1). Consequently, the RDCs served
for the structure validation.
3.2. Description of the structure
The resulting structure of coactosin (PDB id, 1wm4) shares
the fold typical to ADF domains. There are ﬁve internal b-
sheets, i.e., b1 (residues 26–32), b2 (residues 35–42), b3 (resi-
dues 57–64), b4 (residues 75–82) that are anti-parallel and b5
(residues 110–114) that runs parallel to b4. The b-sheets are
surrounded by four a-helices, i.e., a1 (residues 7–16), a2 (res-
idues 45–51) and a3 (residues 88–103) that are parallel to b-
sheets, and a4 (residues 122–131), which packs perpendicular
to the b3 and b4-sheets. The C-terminal residues 132–142 are
disordered (Fig. 1) and ﬂexible on the basis of relaxation data.
The hydrophobic core residues of the protein were identiﬁed
using the criterion of the solvent accessible surface less than
10% and that amide proton of the residue is in slow exchange
with water. Core includes residues Ile5, Cys10, Ala13, Tyr14,
Val17, Trp26, Val27, Phe29, Tyr31, Ile36, Tyr45, Phe48,
Cys52, Leu58, Phe59, Ala60, Phe61, Val62, Phe64, Phe76,
Ala77, Leu78, Ile79, Trp81, Thr94, Phe112, Ile114, Leu120
and Ile125.
3.3. Comparison with other ADF-H domains
The three dimensional structure of coactosin is similar to
yeast coﬁlin (PDB id, 1cfy) [26] with RMSD 2.2 A, and to
the N-terminal domain of mouse twinﬁlin, N-twinﬁlin (1m4j)
[27] 2.9 A (Fig. 2B) although the amino acid sequence
Fig. 1. Overall structure of the coactosin protein. (A) Main chain
representation of the (15) lowest energy structures superimposed on
one another. Residues are color-coded according to the T2 relaxation
times. Dark blue represents the residues with T2 close to the mean
value (region indicated with residue numbers), violet when 35–90% and
magenta when over 90% increase in T2‘s were observed and light blue
when not measured. (B) A schematic ribbon representation of coact-
osin. The structure is colored from green (N-terminus) via blue to red
to orange (C-terminus). (C) Same as (B) after a 120 rotation relative
to the vertical axis. This and all subsequent ﬁgures were produced with
the program MOLMOL [33] unless otherwise stated.
Table 1
Structural statistic for the family of 15 structures of coactosin
NOEASSIGN/
CYANA
XPLOR
NOE upper distance limits
Total 2435
Sequential 1281
1 < ji jj6 4 422
ji jjP 5 732
Additional angle restraints used in CYANAa
Distance constraint violation
Number >0.5 A 1 0
Torsion angle constraint violation
Number >5 0 0
Coordinate precisiona (A)
Res. 3–130
Backbone 0.74 0.92
All heavy atoms 1.14 1.43
Res. 3–66, 73–130
Backbone 0.39 0.64
All heavy atoms 0.84 1.19
Ramachandran analysisb (%) Ensemble
Most favored 77.1 70.7
Additionally allowed 22.6 23.5
Generously allowed 0.3 3.9
Disallowed 0.0 1.9
Target function value (A2) (CYANA)
Averave/best 1.68/1.31
RMSD from idealized geometry (XPLOR)
Bond lengths (A) 0.002 0.0001
Bond angles () 0.30 0.01
Improper torsions () 0.30 0.02
RMSDs from experimental restraints
NOE distance constraints (A) 0.03 0.002
Dihedral constraints () 0.57 0.20
Dipolar coupling constraints (Hz) 0.71 0.04
aRamachandran angle constraints for 131 and rotamer angle con-
straints for 200 residues were obtained, which improves the coordinate
precision signiﬁcantly.
bCalculated using PROCHECK-NMR [35].
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less than 25%.
The residues important for F-actin binding are structurally
conserved, including Lys72 and Lys75, corresponding to Lys79
and Lys82 in coﬁlin. The minor diﬀerences in the actin binding
surfaces of coactosin, coﬁlin and N-twinﬁlin, are caused by the
substitution of the amino acids important for G-actin binding
in the region of long a3-helix.
The conserved tyrosines, present in ADF/coﬁlins’ structures,
i.e., Tyr64 and Tyr101 in yeast coﬁlin, are suggested to stabi-
lize and orient the long a3-helix. Hydrogen bond is suggested
between the side chain hydroxyl of Tyr64 and the main chain
carbonyl of Tyr101. In coactosin, these residues are substituted
by Phe59 and Thr94 with the absence of corresponding hy-
drogen bond. However, structural fold of the coactosin is
maintained by diﬀerent packing to where Tyr31 (b1-sheet) is
also involved. The side chain of Tyr31 lies close to Thr94 in the
same location as the aromatic ring of Tyr101 of coﬁlin, but in a
perpendicular orientation (Fig. 3). Hydroxyl of the Tyr31 side
chain is pointing towards the face of phenyl group of the Phe59
while hydroxyl of the Thr94 side chain is pointing towards the
face of phenol group of the Tyr31. In spite of distinct stabil-
ization mechanisms, distances between the main chains of a3-
helix and b3-sheet are equal in coactosin and coﬁlin. Totally
solvent exposed Ile36 (b2-sheet) is also sandwiched betweenthe a3-helix and the core of the protein. The conserved phos-
phorylation site Ser4 in coﬁlin is replaced with Thr3 in co-
actosin, which lies close to the a3-helix. The phosphorylation is
not proven for coactosin.4. Discussion
The solution structure proves that coactosin has the same
fold of ADF/coﬁlins and the N-twinﬁlin [26,27]. Thus, it be-
longs to the same ADF-H protein family as ADF/coﬁlins,
twinﬁlins and Abp1/drebrins and should be considered as the
fourth member to this protein family.
Comparison with other known ADF-H domains revealed
conservation in the surface residues known to be important for
actin ﬁlament interactions in ADF/coﬁlin proteins [28,29].
Furthermore, the structural alignment of coactosin with yeast
coﬁlin veriﬁes that Lys75, which was previously reported to be
essential for actin binding in coactosin [9], corresponds to
Lys82 of coﬁlin. Mutagenesis studies have demonstrated that
in coﬁlin this residue is imperative to the actin ﬁlament binding
[28]. Also, the chemical character of the actin-binding surface
of ADF/coﬁlins and coactosin are similar to each other. This
Fig. 2. Structural comparison of coactosin, yeast coﬁlin and N-twinﬁlin. (A) Structural sequence alignment. The secondary structure elements of
coﬁlin, coactosin and N-twinﬁlin are indicated above and below the sequences. Acidic and basic amino acids are color-coded with light blue and grey
rectangles, respectively. The residues that have been shown to be important to actin monomer and ﬁlament interactions in ADF/coﬁlins and N-
twinﬁlin are marked with orange diamond and violet triangle, respectively. The key residues for a3-helix stabilization in ADF-H domains and
corresponding residues in coactosin (the residues represented in Fig. 3) are marked with circles. (B) Ribbon diagrams of coactosin, coﬁlin (residues 6–
138 shown, crystal structure) and N-twinﬁlin (residues 7–139 shown, crystal structure). The side chains of the residues important for F-actin and
G-actin binding in coﬁlin are color-coded as in (A). Also the residues conserved in coactosin are indicated with the same color scheme and the
corresponding residues are labelled to coﬁlin and N-twinﬁlin. Orange colored circles schematically indicate positions of N-terminal residues of coﬁlin
and N-twinﬁlin involved in G-actin binding. Aligned secondary structure elements of the three proteins are equally colored. Structure-based su-
perposing was applied with the program DALI [34].
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through the conserved interface.
ADF-H domains have a common mechanism for the sta-
bilization of the long a3-helix, which is based on the highly
conserved tyrosines (Tyr64 and Tyr101). The sequence of the
coactosin lacks these particular residues, however, the stable
fold and the typical orientation of a3-helix isachieved by a
distinct packing mechanism.
Interestingly, coactosin binds to actin ﬁlaments with sig-
niﬁcantly lower aﬃnity than ADF/coﬁlins. Under physio-
logical conditions, the aﬃnity of Dictyostelium coactosin to
F-actin is 3 lM [8] and the one of mammalian coactosin is
approximately 10 lM [30, Naumanen et al., unpublished].
Under similar conditions the aﬃnities of ADF/coﬁlins to F-
actin are 0.5–1 lM [31,32]. However, in cells coactosin
localizes to certain actin ﬁlament structures (Naumanen
et al., unpublished) indicating a strong connection between
coactosin and actin ﬁlaments in cells. This suggests that invivo the localization of coactosin to actin ﬁlaments may be
enhanced by interactions with other proteins or by post-
translational modiﬁcation(s) that will increase its aﬃnity to
actin. Small structural diﬀerences between coﬁlin and co-
actosin that were revealed in this study may thus be re-
sponsible for coactosin’s relatively weak actin aﬃnity in
vitro. We propose that activation of coactosin in cells, either
through a post-translational modiﬁcation or by interaction
with other currently uncharacterized protein, changes the
conformation of coactosin to more ‘coﬁlin-like’ and thus
increases its aﬃnity to actin and consequently localizes it to
the actin cytoskeleton. In the future it will be important to
examine the mechanism of coactosin–actin interaction and
to reveal how the activity and localization of coactosin are
regulated in cells. These studies will also provide the basis
for understanding the role of this highly conserved actin-
binding protein in cytoskeletal dynamics and various cell
processes.
Fig. 3. Representation of the structural basis of the stabilization of the long a3-helix (A) in coactosin and (C) in yeast coﬁlin (highly conserved in the
ADF-H domains). In (B) and (D) are shown the same models as in A and C, respectively, rotated by 90 relative to y-axis. Locations of the important
residues in the primary structure are shown in Fig. 2A with circles and are colored according to their position. Corresponding secondary structure
elements are marked with similar but lighter shading.
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